A lot of progress has been made in metabolic studies in the past few years, and substances that change how cells use energy are getting a lot of attention. One of these new molecules, SLU-PP-332 capsule, has shown a lot of promise as a way to study metabolic control and energy balance. This man-made activator works with certain nuclear receptors to change how cells use energy sources. This information is useful for metabolic studies, biotechnology labs, and pharmaceutical research. SLU-PP-332 Capsule is increasingly studied in metabolic and cellular research for its role in regulating energy metabolism and signaling pathways. It helps researchers explore how metabolic signals affect cellular machinery and identify potential therapeutic targets. Its action involves estrogen-related receptor activation, molecular docking, conformational changes, and downstream gene expression. These mechanisms influence metabolic pathways, making it valuable for pharmaceutical research, CDMO development, and experimental studies of metabolic disorders research applications.
SLU-PP-332 Capsules
1.General Specification(in stock)
(1)API(Pure powder)
(2)Tablets
(3)Capsules
(4)Injection
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code: BM-6-012
4-hydroxy-N'-(2-naphthylmethylene)benzohydrazide CAS 303760-60-3
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Xi'an Factory
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide SLU-PP-332 capsule, please refer to the following website for detailed specifications and product information.
Product:https://www.bloomtechz.com/oem-odm/capsule-softgel/slu-pp-332-capsules.html
How SLU-PP-332 Activates Estrogen-Related Receptors to Influence Metabolic Gene Expression?
Molecular Interaction with ERR Alpha and Gamma Isoforms
As a specific agonist for estrogen-related receptors (ERRs), SLU-PP-332 works on ERR-alpha and ERR-gamma versions. These nuclear receptors control regulatory processes that manage how cells use energy, how mitochondria work, and how cells breathe. The chemical attaches to the ligand-binding region of these receptors, changing its shape in a way that makes it easier for coactivators to join and increases transcriptional activity.
Researchers have found that SLU-PP-332 is much more selective for ERR subtypes than for standard estrogen receptors. This makes it a useful tool for figuring out how ERR-specific metabolic pathways work. The binding preference and subsequent activation of the receptor set off a chain of molecular events that changed the metabolism of cells so that they could make reactive energy. Because of this, researchers can study ERR-dependent processes without other nuclear receptor families getting in the way.
Transcriptional Activation of Oxidative Metabolism Genes
When SLU-PP-332 Capsule turns them on, estrogen-related receptors move to specific DNA response elements in the promoter areas of genes they are supposed to target. These genes make proteins that are very important for fatty acid oxidation, oxidative phosphorylation, and mitochondrial formation. The transcriptional machinery that is called in by active ERRs includes coactivators like PGC-1alpha, which makes the metabolic gene expression program stronger.
Gene expression analysis studies show that treating cells with SLU-PP-332 increases the expression of many genes that are involved in electron transport chain components, fatty acid transport proteins, and enzymes that help with beta-oxidation. This organized pattern of gene expression changes the metabolism of cells so that they can use oxygen more efficiently. Because the compound can change these genetic programs, it is very useful for study labs that are looking into metabolic flexibility and adaptability.
Temporal Dynamics of Metabolic Gene Regulation
The rates at which gene expression changes after SLU-PP-332 treatment follow clear patterns of time. Within hours, early-response genes start to work, and then secondary waves of metabolic enzyme activation happen. This timing coordination makes sure that the metabolic machinery is put together correctly and stops cellular stress from happening when energy-producing parts don't work together properly. Researchers using the SLU-PP-332 Capsule in time-course studies see increasing levels of oxidative capacity markers. This suggests that the capsules cause long-lasting metabolic change rather than short-term effects. Because the substance has a long-lasting effect, it can be used to study long-term changes in metabolism and how cells respond to metabolic cues.
Metabolic Shifts and Increased Fatty Acid Utilization with SLU-PP-332 Capsules
Enhancement of Beta-Oxidation Pathways
Treatment with SLU-PP-332 Capsule greatly increases the ability of experimental models to oxidize fatty acids. The chemical increases the activity of carnitine palmitoyltransferase enzymes, which help move fatty acids into the mitochondria, where beta-oxidation takes place. In addition, enzymes that directly break down fatty acids become more active and have higher expression levels after being exposed to SLU-PP-332. Metabolic flux studies show that cells that have been treated with this substance prefer to use fatty acids for energy production instead of glucose metabolism.This metabolic substrate choice is similar to changes seen in oxidative cells during fasting or endurance training, which shifts them toward using lipids.
Because SLU-PP-332 Capsule can cause these changes without actually putting the metabolism under stress, it is a very useful tool for studying metabolic flexibility.
Substrate Partitioning and Metabolic Flexibility
SLU-PP-332 does more than just increase the burning of fatty acids. It also improves metabolic flexibility, which means that the body can use a variety of fuel sources depending on what is available. When cells are exposed to this substance, they are better able to use different fuels for energy production, such as long-chain fatty acids, ketone bodies, and amino acids.This metabolic flexibility comes from having more mitochondria and more enzymes working in more than one breakdown route.
When SLU-PP-332 Capsule is given to research models, they depend less on glycolytic metabolism, which means that their rates of making lactate and using glucose go down. Understanding metabolic diseases like insulin resistance and metabolic syndrome, which are marked by metabolic inflexibility, is greatly helped by the shift toward oxidative metabolism. This compound is useful for target confirmation tests for drug makers working on metabolic therapeutics.
Lipid Handling and Cellular Energy Status
SLU-PP-332 changes not only how lipids are oxidized, but also how cells handle lipids.
The chemical changes the production of proteins that move lipids, the movement of lipid droplets inside cells, and the pathways that sense lipids. These regulated changes stop lipotoxicity and get the most energy from fatty acid sources. When SLU-PP-332 is applied to oxidative tissues, cellular energy state signs like ATP/ADP ratios and phosphocreatine levels get better. This higher ability to make energy is accompanied by lower levels of metabolic stress markers, which suggests that the substance encourages efficient metabolic activity rather than extra activity. These well-defined metabolic markers are useful for biotechnology companies that do metabolic phenotyping studies.
Mitochondrial Biogenesis and Energy Production Enhancement Through SLU-PP-332
Stimulation of Mitochondrial Proliferation and Function
SLU-PP-332 Capsule turns on transcriptional programs that make mitochondria grow. This is how cells raise the amount and size of mitochondria. This includes regulated production of genes that are stored in the nucleus and those that are stored in the mitochondria. These genes are needed to build mitochondria that work. The substance raises the levels of transcription factors like NRF1 and TFAM. These factors control the copying of DNA in mitochondria and the building of organelles. Studies using electron imaging on tissues that were exposed to SLU-PP-332 Capsule show that the mitochondria are denser and the cristae are better structured, which means that the cells can breathe better.
Functional tests using high-resolution respirometry show higher oxygen consumption rates and better electron transport and ATP synthesis linking efficiency. These structural and functional changes really make the system for making energy in cells better.
Antioxidant Defense Systems and Mitochondrial Quality Control
In addition to raising the number of mitochondria, SLU-PP-332 improves their quality by activating more antioxidant defense systems.
More of the enzymes superoxide dismutase, catalase, and glutathione-related enzymes are being made, which protects cell parts from oxidative damage.This balanced method makes sure that increased metabolic activity doesn't lead to the buildup of dangerous reactive oxygen species. The chemical also changes quality control systems in mitochondria, such as mitophagy, which breaks down broken mitochondria one by one. This improvement to quality control makes sure that mitochondria that are multiplying keep their functional integrity. Researchers who are interested in mitochondrial medicine use SLU-PP-332 Capsule to look into the connections between mitochondrial production, quality control, and metabolic health.
Exercise-Mimetic Effects and Endurance-Like Adaptations in Research Models
Replication of Metabolic Changes Caused by Training
One interesting thing about SLU-PP-332 Capsule is that it can change your metabolism in ways that are similar to what happens when you do physical exercise. Researchers who treated models with this substance saw higher levels of genes that are usually turned up by exercise.
These genes include those that control mitochondrial activity, angiogenesis, and oxidative metabolism. Experimental models' endurance ability is improved by SLU-PP-332 Capsule treatment, according to functional performance tests, even without any exercise training. Because the compound acts like exercise, it can help us figure out which chemical paths cause training changes. This is especially important for pharmaceutical experts looking for therapeutic targets for diseases that make exercise hard or impossible.
Vascular and Tissue Adaptation Mechanisms
SLU-PP-332 affects changes at the tissue level, such as angiogenesis and capillary density gains, in addition to metabolism changes within individual cells. The substance raises levels of vascular endothelial growth factor (VEGF) and related angiogenic factors. This helps new blood vessels form, which improves the supply of oxygen and nutrients to tissues.
These changes in the vascular system go along with the metabolic gains in the cells, making a whole body reaction that is similar to the effects of exercise training. Biotechnology labs that study metabolic efficiency and tissue regrowth use SLU-PP-332 Capsule to break down the molecular signals that control these complex changes at multiple levels.
Integrating SLU-PP-332 Capsules into Experimental Metabolic Efficiency Studies
Experimental Design Considerations for Metabolic Research
When adding SLU-PP-332 Capsule to study methods, dosing schedules, treatment length, and when to measure outcomes need to be carefully thought out. The pharmacokinetic features of the drug, such as its intake, distribution, and clearance rates, affect how the experiments are set up. Dose-response studies are often used by researchers to find the best amounts that have strong metabolic effects without putting too much stress on cells.
Combining SLU-PP-332 Capsule treatment with a wide range of analysis methods, such as metabolomics, transcriptomics, and functional tests, is helpful for metabolic phenotyping studies. This multidimensional study shows how the chemical affects metabolic pathways that are linked to each other and finds any possible side effects. Contract research companies that do metabolic studies like how well-characterized the chemical is and how its effects can be repeated.
Quality Standards and Analytical Confirmation
For high-quality study, chemical purity and identity must be rigorously checked by analysis. HPLC, mass spectrometry, and NMR spectroscopy should all show that SLU-PP-332 used in study should meet strict quality standards, with purity levels usually higher than 98%. Documentation for the certificate of analysis tells you important things about the chemical qualities and accuracy of the batch. To stay stable and stop breaking down, research-grade SLU-PP-332 Capsule needs to be stored in the right way. Controlling the temperature, blocking light, and keeping moisture out of the compound keep its integrity during the testing periods. Pharmaceutical businesses and biotechnology labs that are doing GLP-compliant studies really value providers that offer full analytical data and quality assurance.
Regulatory Compliance and Documentation Requirements
Companies doing regulated study or making therapeutic uses need providers who know what kind of paperwork is needed for regulatory purposes. This includes full chemical analysis, impurity profiles, stability data, and details about the production process. Suppliers of SLU-PP-332 that help with pharmaceutical research provide paperwork that is compatible with regulatory applications, such as INDs and NDAs. Traceability along the entire supply chain makes sure that study results can be defended and used again. Chain-of-custody records, batch-specific paperwork, and quality management system certifications give people faith in the authenticity and consistency of the material. When it comes to chemical products, CDMOs that work with pharmaceutical companies really value providers that can offer regulatory help and technical knowledge.
Conclusion
SLU-PP-332 Capsule is a high-tech research tool for studying how metabolism works, how mitochondria work, and how cells keep their energy levels stable. It works by activating estrogen-related receptors, which gives researchers exact control over how metabolic genes are expressed. The chemical causes regulated changes in the metabolism, such as better fatty acid oxidation, mitochondrial biogenesis, and changes that are similar to exercise reactions in the body. When it comes to metabolic disease study, target validation studies, and learning how cells adapt, SLU-PP-332 Capsule is very useful for pharmaceutical companies, biotechnology labs, research organizations, and CDMOs. The compound can be used for thorough scientific studies that need reliable chemical tools because its properties and effects can be repeated. To successfully add SLU-PP-332 to study projects, you need high-quality materials that meet strict purity standards, detailed analytical documentation, and strong partnerships in the supply chain. Choosing suppliers with a track record of knowing a lot about pharmaceutical intermediates, legal compliance, and technical help is the best way to make sure that study goals are met quickly and correctly.
FAQ
1. What makes SLU-PP-332 Capsule different from other chemicals used in metabolic research?
+
-
SLU-PP-332 works by selectively activating estrogen-related receptors (ERR-alpha and ERR-gamma) instead of standard estrogen receptors. This makes it specific for metabolic pathways without affecting hormones. Researchers can study ERR-dependent metabolic control, such as mitochondrial biogenesis, fatty acid oxidation, and improving oxidative metabolism, with this selection. The compound has effects similar to exercise by starting up transcriptional programs that are usually set off by endurance training. This makes it very useful for studying metabolic changes and finding new ways to treat metabolic diseases.
2. What should I look for in terms of quality when I'm looking for SLU-PP-332 for study purposes?
+
-
Multiple testing methods, such as HPLC, mass spectrometry, and NMR spectroscopy, should show that research-grade SLU-PP-332 Capsule is at least 98% pure. Full reports of analysis should include information about the chemical's name, purity, impurity profiles, and stability. For pharmaceutical study purposes, providers should offer materials that were made according to Good Manufacturing Practice (GMP) guidelines along with the right paperwork, such as batch records, analytical methods, and regulatory support files. The safety of the compound during the trial timeline is guaranteed by the right storage conditions and handling directions.
3. How do pharmaceutical companies usually add SLU-PP-332 to metabolic research projects?
+
-
Pharmaceutical companies use SLU-PP-332 Capsule for many types of research, such as target validation studies for metabolic diseases, mechanism-of-action investigations, and biomarker finding programs. The molecule works as a molecular probe to turn on ERR signaling pathways. This helps researchers figure out how these pathways affect glucose metabolism, lipid handling, and mitochondrial function. Studies of dose-response, time-course gene expression, metabolic flux measures, and functional phenotyping tests are some of the most common uses. For integration to work, suppliers must be able to consistently provide high-quality materials, full technical support, and documents that can be used in regulated study settings.
Partner with BLOOM TECH - Your Trusted SLU-PP-332 Capsule Supplier
BLOOM TECH is a reliable supplier of high-purity SLU-PP-332 Capsules with over 12 years of experience in pharmaceutical intermediates. Our GMP-certified facilities meet US-FDA, EU-GMP, and CFDA standards. We provide ≥98% purity compounds with full analytical data and strict quality control. Flexible production, transparent pricing, and technical support ensure consistent, scalable supply for metabolic research and development projects worldwide. Ready to advance your metabolic research with premium-quality SLU-PP-332 Capsule? Get in touch with our knowledgeable staff right away at Sales@bloomtechz.com to talk about your unique needs, ask for full analytical documentation, or get a personalized quote. Let BLOOM TECH become your reliable partner in getting the pharmaceutical intermediates that help scientists find new things.
References
1. Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008;134(3):405-415.
2. Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocrine Reviews. 2008;29(6):677-696.
3. Rangwala SM, Wang X, Calvo JA, et al. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. Journal of Biological Chemistry. 2010;285(29):22619-22629.
4. Ahmadian M, Suh JM, Hah N, et al. PPARγ signaling and metabolism: the good, the bad and the future. Nature Medicine. 2013;19(5):557-566.
5. Lynch GS, Ryall JG. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiological Reviews. 2008;88(2):729-767.
6. Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et Biophysica Acta. 2011;1813(7):1269-1278.